Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
New World Medical launches non-valved glaucoma drainage device, Ahmed ClearPath ST
(Image Credit: AdobeStock) New World Medical has launched Ahmed ClearPath ST, a non-valved glaucoma drainage device. The company stated in a press release that the Ahmed ClearPathST builds on the success of the Ahmed ClearPath by introducing key differences designed to…
CorNeat Vision's Artificial Cornea Restores Perfect 20/20 Vision in Shingles-Blinded Eye – PR Newswire
CorNeat Vision’s Artificial Cornea Restores Perfect 20/20 Vision in Shingles-Blinded Eye PR Newswire Source: Author: | Date: 2025-09-02 15:14:00 Source: Author: | Date: 2025-09-02 15:14:00
EMA grants Orphan designations to MCO-010, FDA grants RMAT in Stargardt disease
(Image credit: AdobeStock/Pete) The European Medicines Agency (EMA) granted Orphan designations to MCO-010 (sonpiretigene isteparvovec) across 5 categories of retinal dystrophies. The US Food and Drug Administration (FDA) also granted RMAT designation for MCO-010 in Stargardt disease (SD). The EMA…
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – The Globe and Mail
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones The Globe and Mail Source: Author: | Date: 2025-09-02 12:12:00 Source: Author: | Date: 2025-09-02 12:12:00
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Company Announcement – FT.com – Financial Times
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Company Announcement – FT.com Financial Times Source: Author: | Date: 2025-09-02 12:00:00 Source: Author: | Date: 2025-09-02 12:00:00
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Laotian Times
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones Laotian Times Source: Author: | Date: 2025-09-02 12:00:00 Source: Author: | Date: 2025-09-02 12:00:00
The future of ophthalmology training is here—and it’s digital
(Image Credit: AdobeStock/Pixel-Shot) In recent years, advancements in technology have revolutionized ophthalmology education, transforming the traditional learning environment into a highly dynamic digital experience. Surgical simulators, such as Eyesi (Haag-Streit) and Eye Surgery Simulator (HelpMeSee), offer valuable hands-on practice that…
Are prostaglandins really the most effective glaucoma therapy? – Eyes On Eyecare
Are prostaglandins really the most effective glaucoma therapy? Eyes On Eyecare Source: Author: | Date: 2025-09-01 18:54:00 Source: Author: | Date: 2025-09-01 18:54:00
Sharp Weight Loss from Childhood to Adulthood May Raise Glaucoma Risk: Study Shows – Medical Dialogues
Sharp Weight Loss from Childhood to Adulthood May Raise Glaucoma Risk: Study Shows Medical Dialogues Source: Author: | Date: 2025-09-01 15:15:00 Source: Author: | Date: 2025-09-01 15:15:00
New insights show “later is better” for some LHON interventions
(Image Credit: AdobeStock/Brian Jackson) Neuro-ophthalmologist Alfredo Sadun, MD, PhD, has helped uncover surprising results from gene therapy research for Leber hereditary optic neuropathy (LHON), revealing effects far beyond the initially treated eye. LHON is a rare genetic disorder that causes…